Literature DB >> 11522644

MLL-ENL causes a reversible and myc-dependent block of myelomonocytic cell differentiation.

S Schreiner1, M Birke, M P García-Cuéllar, O Zilles, J Greil, R K Slany.   

Abstract

The translocation t(11;19) is a recurrent feature of a subgroup of acute leukemias occurring in infants. This event fuses the genes MLL and ENL and creates the leukemogenic oncoprotein MLL-ENL. We studied the effect of retroviral MLL-ENL expression in primary mouse hematopoietic cells and show here that MLL-ENL requires the oncoprotein Myc to establish a reversible differentiation arrest of a myelomonocytic precursor population. MLL-ENL-transduced cells proliferated as immature myeloid cells in the presence of interleukin 3. The addition of granulocyte colony-stimulating factor reversed the maturation block set by MLL-ENL and induced the development of mature granulocytes and macrophages accompanied by growth arrest. Gene expression analysis indicated a down-regulation of the proto-oncogene c-myc and of several c-myc target genes during granulocyte colony-stimulating factor-mediated differentiation. The role of c-myc in the MLL-ENL transformation pathway was tested by modulating the effective Myc protein concentrations in MLL-ENL transduced cells. Cotransduction of dominant-negative Myc neutralized the MLL-ENL effect and precluded transformation. In contrast, constitutive expression of Myc cooperated with MLL-ENL and caused the transformation of a cell population with an irreversible maturation arrest.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11522644

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  27 in total

1.  Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization.

Authors:  Bernd B Zeisig; Tom Milne; María-Paz García-Cuéllar; Silke Schreiner; Mary-Ellen Martin; Uta Fuchs; Arndt Borkhardt; Sumit K Chanda; John Walker; Richard Soden; Jay L Hess; Robert K Slany
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

2.  c-Myc-mediated control of cell fate in megakaryocyte-erythrocyte progenitors.

Authors:  Yinshi Guo; Chao Niu; Peter Breslin; Minghui Tang; Shubin Zhang; Wei Wei; Ameet R Kini; Gladell P Paner; Serhan Alkan; Stephan W Morris; Manuel Diaz; Patrick J Stiff; Jiwang Zhang
Journal:  Blood       Date:  2009-04-16       Impact factor: 22.113

3.  Loss of MLL PHD finger 3 is necessary for MLL-ENL-induced hematopoietic stem cell immortalization.

Authors:  Jing Chen; Donna A Santillan; Mark Koonce; Wei Wei; Roger Luo; Michael J Thirman; Nancy J Zeleznik-Le; Manuel O Diaz
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

4.  Effects of common atopy-associated amino acid substitutions in the IL-4 receptor alpha chain on IL-4 induced phenotypes.

Authors:  Izolda Franjkovic; Andre Gessner; Inke König; Karin Kissel; Anette Bohnert; Anne Hartung; Astrid Ohly; Andreas Ziegler; Holger Hackstein; Gregor Bein
Journal:  Immunogenetics       Date:  2005-01-27       Impact factor: 2.846

Review 5.  Two decades of leukemia oncoprotein epistasis: the MLL1 paradigm for epigenetic deregulation in leukemia.

Authors:  Bin E Li; Patricia Ernst
Journal:  Exp Hematol       Date:  2014-09-28       Impact factor: 3.084

6.  MLL-ENL cooperates with SCF to transform primary avian multipotent cells.

Authors:  Cathleen E Schulte; Marieke von Lindern; Peter Steinlein; Hartmut Beug; Leanne M Wiedemann
Journal:  EMBO J       Date:  2002-08-15       Impact factor: 11.598

7.  The PHD3 domain of MLL acts as a CYP33-regulated switch between MLL-mediated activation and repression .

Authors:  Sangho Park; Ute Osmers; Gayathree Raman; Rebecca H Schwantes; Manuel O Diaz; John H Bushweller
Journal:  Biochemistry       Date:  2010-08-10       Impact factor: 3.162

8.  Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemia.

Authors:  Xi Jiang; Hao Huang; Zejuan Li; Yuanyuan Li; Xiao Wang; Sandeep Gurbuxani; Ping Chen; Chunjiang He; Dewen You; Shuodan Zhang; Jinhua Wang; Stephen Arnovitz; Abdel Elkahloun; Colles Price; Gia-Ming Hong; Haomin Ren; Rejani B Kunjamma; Mary Beth Neilly; Jonathan M Matthews; Mengyi Xu; Richard A Larson; Michelle M Le Beau; Robert K Slany; Paul P Liu; Jun Lu; Jiwang Zhang; Chuan He; Jianjun Chen
Journal:  Cancer Cell       Date:  2012-10-16       Impact factor: 31.743

9.  Misguided transcriptional elongation causes mixed lineage leukemia.

Authors:  Dorothee Mueller; María-Paz García-Cuéllar; Christian Bach; Sebastian Buhl; Emanuel Maethner; Robert K Slany
Journal:  PLoS Biol       Date:  2009-11-24       Impact factor: 8.029

10.  Oncogenic RAS enables DNA damage- and p53-dependent differentiation of acute myeloid leukemia cells in response to chemotherapy.

Authors:  Mona Meyer; Daniela Rübsamen; Robert Slany; Thomas Illmer; Kathleen Stabla; Petra Roth; Thorsten Stiewe; Martin Eilers; Andreas Neubauer
Journal:  PLoS One       Date:  2009-11-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.